Iván Álvarez‐Twöse

Also affiliated with Hospital Virgen del Valle, Spanish Clinical Research Network, Servicio de Salud de Castilla La Mancha, Centro de Investigación Biomédica en Red de Cáncer

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial”.

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Nature Medicine(2021)10.1038/s41591-021-01539-8

N/A

4.0DataRank · unranked

147 citations

Andreas Reiter, Deepti Radia, Michael W. Deininger, Tracy I. George, Jens Panse +19 more

Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.06.011

N/A

0DataRank · unranked

82 citations

Cem Akin, Patrizia Bonadonna, Frank Siebenhaar, Sigurd Broesby‐Olsen, Knut Brockow +27 more

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.03.041

N/A

0DataRank · unranked

41 citations

Knut Brockow, Marek Niedoszytko, Hanneke Oude Elberink, Cem Akin, Bogusław Nedoszytko +28 more

Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.05.007

N/A

0DataRank · unranked

89 citations

Karin Hartmann, Patrizia Bonadonna, Theo Gülen, Knut Brockow, Iván Álvarez‐Twöse +27 more

Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.03.007

N/A

0DataRank · unranked

70 citations

Karin Hartmann, Juliana Schwaab, Iván Álvarez‐Twöse, Knut Brockow, Patrizia Bonadonna +22 more

Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.05.034

N/A

0DataRank · unranked

21 citations

Juliana Schwaab, William Shomali, Tracy I. George, Deepti Radia, Mariana Castells +27 more

The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT

The Journal of Allergy and Clinical Immunology In Practice(2023)10.1016/j.jaip.2023.08.008

N/A

0DataRank · unranked

47 citations

Gregor Hoermann, Patrizia Bonadonna, Karin Hartmann, Wolfgang R. Sperr, Sigurd Broesby‐Olsen +27 more

Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM

The Journal of Allergy and Clinical Immunology In Practice(2024)10.1016/j.jaip.2024.08.044

N/A

0DataRank · unranked

33 citations

Karin Hartmann, Gregor Hoermann, Andreas Reiter, Iván Álvarez‐Twöse, Knut Brockow +24 more

Management of Mastocytosis and Mast Cell Activation in Children

The Journal of Allergy and Clinical Immunology In Practice(2025)10.1016/j.jaip.2025.11.016

N/A

0DataRank · unranked

2 citations

Magdalena Lange, Iván Álvarez‐Twöse, Joanna Renke, Cristina Morales‐Cabeza, Horacio Caligaris +2 more